Blog
5 Dividend ETFs Under $50 to Buy Now
The month-long Middle East conflict saw a temporary de-escalation on April 7, 2026, as Washington and Tehran agreed to a two-week ceasefire, offering short-term relief to markets. However, risks
Robust Trading, IB Fee Growth to Support Morgan Stanley's Q1 Earnings
Morgan Stanley MS is slated to announce first-quarter 2026 earnings on April 15 before the opening bell. As always, the company’s financial performance and the ensuing management conference call are
Does Extreme Networks (EXTR) Have the Potential to Rally 32.39% as Wall Street Analysts Expect?
Extreme Networks (EXTR) closed the last trading session at $17.66, gaining 23.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Think First American Financial (FAF) Could Surge 28.15%: Read This Before Placing a Bet
Shares of First American Financial (FAF) have gained 1% over the past four weeks to close the last trading session at $63.99, but there could still be a solid upside left in the stock if short-term
How Much Upside is Left in Hawkins (HWKN)? Wall Street Analysts Think 27.26%
Hawkins (HWKN) closed the last trading session at $147.73, gaining 5.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%
Galecto, Inc. (DMRA) closed the last trading session at $26.69, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
Shares of Omeros (OMER) have gained 4.3% over the past four weeks to close the last trading session at $11.91, but there could still be a solid upside left in the stock if short-term price targets
How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%
Shares of Indivior Pharmaceuticals Inc. (INDV) have gained 4.7% over the past four weeks to close the last trading session at $32.31, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 46.16% Upside in Nvidia (NVDA): Can the Stock Really Move This High?
Nvidia (NVDA) closed the last trading session at $183.91, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts See a 32.81% Upside in FTAI Aviation (FTAI): Can the Stock Really Move This High?
Shares of FTAI Aviation (FTAI) have gained 7.6% over the past four weeks to close the last trading session at $255.18, but there could still be a solid upside left in the stock if short-term price
Does SM Energy (SM) Have the Potential to Rally 27.89% as Wall Street Analysts Expect?
Shares of SM Energy (SM) have gained 11.2% over the past four weeks to close the last trading session at $28.33, but there could still be a solid upside left in the stock if short-term price targets
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
Nurix Therapeutics, Inc. (NRIX) closed the last trading session at $16.24, gaining 4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?
Aura Biosciences, Inc. (AURA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AURA's 50-day simple moving average crossed
Wall Street Analysts Think Safehold (SAFE) Could Surge 34.55%: Read This Before Placing a Bet
Shares of Safehold (SAFE) have gained 0.4% over the past four weeks to close the last trading session at $14.79, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 41.27% Upside in Rithm (RITM): Can the Stock Really Move This High?
Rithm (RITM) closed the last trading session at $9.91, gaining 3.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
How Much Upside is Left in VEON (VEON)? Wall Street Analysts Think 62.1%
Shares of VEON Ltd. (VEON) have gained 15.4% over the past four weeks to close the last trading session at $51.14, but there could still be a solid upside left in the stock if short-term price
Is the Options Market Predicting a Spike in Salesforce Stock?
Investors in Salesforce, Inc. CRM need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2026 $120.00 Call had some of the highest implied
4 Value Stocks to Buy as Wall Street Weighs Ceasefire Hopes
The U.S. stock market closed higher on Thursday, as improving geopolitical sentiment helped offset pressure from elevated energy prices. The Dow Jones Industrial Average gained 275.88 points, or
Here's Why Rockwell Automation (ROK) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why Skyward Specialty Insurance (SKWD) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Zoetis (ZTS) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why TE Connectivity (TEL) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
GoDaddy (GDDY) is a Top-Ranked Momentum Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates



